Navigation Links
Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
Date:1/23/2012

NEW YORK, Jan. 23, 2012 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that its Chief Medical Officer, the lead investigator for its PreSERVE Phase 2 clinical trial for AMR-001 for preservation of heart function in post acute myocardial infarction patients, and the President of its subsidiary, Progenitor Cell Therapy, LLC, have been invited to present at the Seventh International Conference on Cell Therapy for Cardiovascular Disease held from January 25-27, 2012 in New York City. The event is being organized by the Cardiovascular Research Foundation and will be held at the Myrna L. Daniels Auditorium in the Vivien and Seymour Milstein Family Heart Center at NYPH/Columbia University Medical Center.

According to the conference, the program will be dedicated to the evolving field of cell-based therapies being developed for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year's conference will focus on preclinical and clinical studies on the path to commercialization, highlighting the status of molecular, cell, and tissue products in addition to delivery systems. Leaders from the international community will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

  • At 4:30 PM on Wednesday, January 25, Andrew L. Pecora, MD, FACP, Chief Medical Officer of NeoStem, will speak on an industry session entitled "Focus on Acute Injury Technologies."
  • At 9:20 AM on Thursday, January 26, Ar
    '/>"/>

  • SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
    2. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
    3. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
    4. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
    5. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
    6. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
    7. On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
    8. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
    9. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
    10. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
    11. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... ALTO, Calif. , Jan. 22. 2015  Varian Medical Systems ... and software, has been honored for its commitment to sustainability ... sustainable companies. Varian is the highest ranked healthcare equipment company ... announced today during the World Economic Forum at ...
    (Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
    (Date:12/24/2014)... SILVER SPRING, Md. , Dec. 24, 2014  United ... that Medtronic, Inc. (NYSE: MDT ) has ... and Drug Administration (FDA) for the use of Medtronic,s ... a newly developed catheter) for use with United Therapeutics, ...
    (Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
    Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
    ... Blood testing requirements removed, VANCOUVER, June 6 ... today that Health Canada has completed its review ... and has removed the,glucose-6-phosphate dehydrogenase (G6PD) screening and ... report Health Canada,s decision to remove,the need for ...
    ... 6 Quintiles,Transnational Corp. today announced the appointment ... Medical and Scientific Officer. Cabell,succeeds Oren Cohen, M.D., ... Strategies., As Chief Medical and Scientific Officer, ... on bioethics and the protection of,human subjects. In ...
    ... until January 2009 in the US ... - Pediatric indication filed with FDA, SMYRNA, Ga., June 6 ... has granted pediatric exclusivity for,Keppra(R) (levetiracetam). The decision was based on ... The Keppra(R) US,639 patent was set to expire in July 2008, ...
    Cached Biology Technology:QLT announces positive Health Canada decision on Aczone(R) 2Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer 2US FDA Grants Pediatric Exclusivity for UCB's Keppra(R) 2US FDA Grants Pediatric Exclusivity for UCB's Keppra(R) 3US FDA Grants Pediatric Exclusivity for UCB's Keppra(R) 4US FDA Grants Pediatric Exclusivity for UCB's Keppra(R) 5
    (Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
    (Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
    (Date:1/22/2015)... , Europe,s most prestigious ... Office to present a video retrospective of the most exciting and ... Christofer Toumazou and Sophie Wilson   A ... Award   Starting on 22 January 2015 on   http://www.epo.org/european-inventor ...
    Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
    ... governments and health organisations around the world. The worry is ... H5N1, to develop the ability to infect humans easily. New ... are badly needed. Now one of the tactics used by ... has been laid bare by structural biologists at the European ...
    ... the maturation of red blood cells. Without a protein ... of organelles called mitochondria and consequently become short-lived, leading ... in Houston in a report that appears online today ... thinking on autophagy, said Dr. Jin Wang, assistant professor ...
    ... soon be a boon to biofuels producers. The genome ... surprisingly minimal repertoire of genes that it employs to ... improvements in enzymes customized for biofuels production. The ... by a team of government, academic, and industry researchers ...
    Cached Biology News:Getting wise to the influenza virus' tricks 2Nixing immaturity in red blood cells 2Lean and mean biomass-degrading fungus reveals capabilities for improved biofuel production 2Lean and mean biomass-degrading fungus reveals capabilities for improved biofuel production 3
    CELLine System cultivation flask (for secreted products)...
    ... is produced by a patented microwave process ... more consistent, even cell attachment, increased cell ... and growth uunder difficult conditions, including reduced ... provide a more ecominic alternative to expensive ...
    ... ABgene's Protein Purification Plates are designed ... SDS-PAGE gels. The 96-well plates feature two ... ends of each well. The wells remain ... with buffer, during which time the protein ...
    ... represents the state-of-the-art in permanent mounting ... permanent preservation of immunohistochemical organic insoluble ... Red, New Fuchsin, and any other ... tissue sections. Clarin can be used ...
    Biology Products: